Kymera Therapeutics, Inc. (KYMR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 6.57B |
| Enterprise Value | 6.29B |
| P/E Ratio | -36.86 |
| PEG Ratio | -6.63 |
| Price/Sales Ratio | 93.86 |
| Price/Book Ratio | 7.79 |
| Enterprise/Revenue | 93.46 |
| Enterprise/EBITDA | -33.52 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -2.85 |
| Operating Margin | -3.34 |
| Return On Assets | -0.18 |
| Return On Equity | -0.22 |
| Revenue | 39.2M |
| Revenue/Share | 1.07 |
| Gross Profit | 39.2M |
| EBITDA | -303.06M |
| Net Income | -311.4M |
| Diluted EPS | -3.69 |
| Total Cash | 690.99M |
| Total Cash/Share | 7.04 |
| Total Debt | 82.22M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 9.83 |
| Book Value Per Share | 15.34 |
| 52-Week Change | 186.47 |
| 52-Week High | 130.05 |
| 52-Week Low | 39.84 |
| Moving Average 50 Days | 108.73 |
| Moving Average 200 Days | 86.18 |
| Average Volume | 849,958 |
| Shares Outstanding | 82.26M |
| % Held by Institutions | 99.94 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |